Evidence map›Paper›PMID 40080190›Full record

ArticleEuropean radiology2025

Liver function estimation using multiphase hepatic CT: diagnostic performance of iodine-uptake and volumetric parameters.

Yasunori Nagayama, Masamichi Hokamura, Narumi Taguchi, Yasuhiro Yokota, Takumi Osaki, Koji Ogasawara, Shinya Shiraishi, Ryuya Yoshida, Ryota Harai, Masafumi Kidoh and 3 more

Abstract read
In one paragraph

Article in European radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yasunori NagayamaDepartment of Diagnostic Radiology, Graduate School of Medical Sciences, Kumamoto University, Chuo-ku, Japan. y.nagayama1980@gmail.com.ORCID http://orcid.org/0000-0003-3280-7346
Masamichi HokamuraDepartment of Diagnostic Radiology, Graduate School of Medical Sciences, Kumamoto University, Chuo-ku, Japan.
Narumi TaguchiDepartment of Diagnostic Radiology, Graduate School of Medical Sciences, Kumamoto University, Chuo-ku, Japan.
Yasuhiro YokotaDepartment of Diagnostic Radiology, Graduate School of Medical Sciences, Kumamoto University, Chuo-ku, Japan.
Takumi OsakiDepartment of Diagnostic Radiology, Graduate School of Medical Sciences, Kumamoto University, Chuo-ku, Japan.
Koji OgasawaraDepartment of Diagnostic Radiology, Graduate School of Medical Sciences, Kumamoto University, Chuo-ku, Japan.
Shinya ShiraishiDepartment of Diagnostic Radiology, Graduate School of Medical Sciences, Kumamoto University, Chuo-ku, Japan.
Ryuya YoshidaDepartment of Diagnostic Radiology, Graduate School of Medical Sciences, Kumamoto University, Chuo-ku, Japan.
Ryota HaraiDepartment of Diagnostic Radiology, Graduate School of Medical Sciences, Kumamoto University, Chuo-ku, Japan.
Masafumi KidohDepartment of Diagnostic Radiology, Graduate School of Medical Sciences, Kumamoto University, Chuo-ku, Japan.
Seitaro OdaDepartment of Diagnostic Radiology, Graduate School of Medical Sciences, Kumamoto University, Chuo-ku, Japan.
Takeshi NakauraDepartment of Diagnostic Radiology, Graduate School of Medical Sciences, Kumamoto University, Chuo-ku, Japan.
Toshinori HiraiDepartment of Diagnostic Radiology, Graduate School of Medical Sciences, Kumamoto University, Chuo-ku, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo investigate whether multiphase hepatic CT can predict liver function measured with indocyanine-green-retention test (ICG-R15) and identify patients with severe liver dysfunction contraindicating major hepatectomy, defined as ICG-R15 ≥ 20%, compared to technetium- MATERIALS AND

methodsThis retrospective study included 118 patients (84 men, mean age, 69.4 ± 11.3 years) who underwent ICG-R15,

resultsIn the ICG-R15 ≥ 20% group, IWR (p < 0.001), LV/BSA (p = 0.026), LHL15 (p < 0.001) were lower and ECV (p = 0.001), SpV/BSA (p = 0.005), and HH15 (p < 0.001) were higher compared to ICG-R15 < 20% group. ICG-R15 showed positive correlations with ECV (r = 0.355), SpV/BSA (r = 0.248), and HH15 (r = 0.385), while negative correlations with IWR (r = -0.523), LV/BSA (r = -0.123, not statistically significant), and LHL15 (r = -0.504). The AUC of ECV, IWR, LV/BSA, SpV/BSA, HH15, and LHL15 were 0.719, 0.845, 0.653, 0.694, 0.844, and 0.878, respectively. IWR, SpV/BSA, and LV/BSA were independent predictors, with a combined AUC of 0.924.

conclusionIWR predicted liver function better than ECV and hepatosplenic volumetry. The combined IWR and volumetry yielded an accurate prediction of severe liver dysfunction. KEY POINTS: Question Despite the widespread use of multiphase CT in patients with hepatobiliary diseases, its potential role in assessing liver function has been scarcely evaluated. Findings Iodine washout rate (IWR), liver volume indexed by body surface area, and spleen volume indexed by body surface area were independent predictors for severe liver dysfunction. Clinical relevance Combined IWR and hepatosplenic volumetry on routine hepatic CT may help assess hepatic function for optimizing treatment strategies and predicting patient prognosis.

Indexed as

IodineLiverLiver DiseasesTomography, X-Ray ComputedAgedAged, 80 and overFemaleHumansIndocyanine GreenLiver Function TestsMaleMiddle AgedRadiopharmaceuticalsReproducibility of ResultsRetrospective StudiesSensitivity and SpecificityIndocyanine GreenIodineRadiopharmaceuticalsTechnetium Tc 99m Aggregated Albumintechnetium Tc 99m DTPA-galactosyl-human serum albuminTechnetium Tc 99m PentetateIodineLiver dysfunctionLiver function testsMultidetector computed tomography

Identifiers

PMID40080190
PMCPMC12350596

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.